These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations. Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073 [TBL] [Abstract][Full Text] [Related]
12. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China. Xue C; Zhou CC; Wu M; Mei CL Kidney Dis (Basel); 2016 Oct; 2(3):111-119. PubMed ID: 27921038 [TBL] [Abstract][Full Text] [Related]
13. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. Sekine A; Hoshino J; Fujimaru T; Suwabe T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y Am J Nephrol; 2020; 51(9):745-751. PubMed ID: 32784291 [TBL] [Abstract][Full Text] [Related]
14. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease. Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial. Irazabal MV; Blais JD; Perrone RD; Gansevoort RT; Chapman AB; Devuyst O; Higashihara E; Harris PC; Zhou W; Ouyang J; Czerwiec FS; Torres VE Kidney Int Rep; 2016 Nov; 1(4):213-220. PubMed ID: 29142926 [TBL] [Abstract][Full Text] [Related]
16. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease. Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715 [TBL] [Abstract][Full Text] [Related]
17. Predicting Future Renal Function Decline in Patients with Autosomal Dominant Polycystic Kidney Disease Using Mayo Clinic Classification. Borrego Utiel FJ; Esteban de la Rosa RJ; Merino García E; Medina Benítez A; Polo Moyano A; Moriana Domínguez C; Morales García AI; Bravo Soto JA Am J Nephrol; 2021; 52(8):630-641. PubMed ID: 34518464 [TBL] [Abstract][Full Text] [Related]
18. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy. Chebib FT; Torres VE Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818 [TBL] [Abstract][Full Text] [Related]
19. [ADPKD: predictors of Renal Disease progression]. Scolari F; Dallera N; Saletti A; Terlizzi V; Izzi C G Ital Nefrol; 2016; 33(5):. PubMed ID: 27796018 [TBL] [Abstract][Full Text] [Related]